Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held on June 15, 2022. The filing details the results of shareholder votes on director elections, auditor ratification, and executive compensation.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes
No material financial changes are reported in this document. The primary event is the successful election of all director nominees and the approval of the independent auditor and executive compensation.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a procedural report of voting outcomes.
Key Facts for Investors
- Director Elections: All nominees were elected. Notably, Vijaya Gadde received 58,003,396 votes for but also 25,125,067 votes withheld, indicating significant shareholder dissent compared to other nominees.
- Auditor Ratification: Shareholders approved the selection of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2022.
- Executive Compensation: The advisory vote on named executive officer compensation was approved, though it received 32,094,830 votes against, representing a substantial portion of the vote.
- Broker Non-Votes: There were 5,543,615 broker non-votes recorded for the director elections and the executive compensation proposal.